NSC |
Compound |
Enrichment |
Correlation |
NSC 724771 |
Null |
0.0490935610249067 |
0.34323166 |
NSC 724827 |
1,4-di-N-oxide-6,7-difluoro-2-ethylcarbonyl-3-trifluoromethy lquinoxaline |
0.0490935610249067 |
0.44279518 |
NSC 724910 |
3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, 10,10'-[(2-hydroxy-1,3-propanediyl)bis(oxy)] bis[decahydro- 3,6,9-trimethyl-, hemisuccinate |
0.0490935610249067 |
0.35202944 |
NSC 726718 |
3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid |
0.0490935610249067 |
0.18332513 |
NSC 727012 |
(2S,3S)-3,4-Epoxy-2-(3-methoxy-5-methyl-1-naphthoyloxy)-3-methylbutanamide |
0.0490935610249067 |
0.16205737 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.0490935610249067 |
0.0045862264 |
NSC 730294 |
Null |
0.0490935610249067 |
0.4587089 |
NSC 730460 |
16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate |
0.0490935610249067 |
0.2209176 |
NSC 731399 |
2-Benzylthio-4-chloro-5-methyl-N-(2,3-dihydro-1H-benzimidazo l-2-yl)benzenesulfonamide |
0.0490935610249067 |
0.091620145 |
NSC 744178 |
Null |
0.0490935610249067 |
0.048734276 |